Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Cell. 2011 Mar 4;144(5):638-40. doi: 10.1016/j.cell.2011.02.030.

Uncovering a tumor suppressor for triple-negative breast cancers.

Author information

  • 1Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

Erratum in

  • Cell. 2011 Apr 29;145(3):483.

Abstract

"Triple-negative" breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.

Copyright © 2011 Elsevier Inc. All rights reserved.

Comment on

PMID:
21376226
[PubMed]

Publication Types

Publication Types

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk